At a time of dramatic increases in the prevalence of obesity, it is appropriate that Type 2 diabetes has received a great deal of attention by the endocrinology community. Clearly, the management of insulin resistance and cardiovascular risk is a critical issue. However, it is important to also ackn
Therapeutic Perspectives in Type-1 Diabetes
โ Scribed by PRACHI SINGH, GANESH R KOKIL, KARNAKER R TUPALLY, KINGSHUK PODDAR, Aaron Tan, VENKY VENKATESAN, HARENDRA S. PAREKH, GIORGIA PASTORIN (auth.)
- Publisher
- Springer Singapore
- Year
- 2016
- Tongue
- English
- Leaves
- 87
- Series
- SpringerBriefs in Applied Sciences and Technology
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
This book provides critical insights into and appraisals of recent breakthroughs in type 1 diabetes modulation, with a particular emphasis on the potential impact of current prevention and treatment strategies. It also discusses recent successes and failures in clinical trials. Presenting an comprehensive overview of the disease, it is especially useful for newcomers in the field. It also includes illustrations, which make it easy for the reader to grasp the basic concepts involved. Furthermore, the tables include concise and easy-to-understand information on current clinical trials.
โฆ Table of Contents
Front Matter....Pages i-viii
Introduction to Diabetes and Type 1 Diabetes....Pages 1-6
Triggers Causing Type 1 Diabetes....Pages 7-20
Predictors and Pathogenesis of Type 1 Diabetes....Pages 21-28
Type 1 Diabetes: Past, Present, and Future Therapies....Pages 29-78
โฆ Subjects
Biomedical Engineering; Medicinal Chemistry; Diabetes
๐ SIMILAR VOLUMES
Third author, Arlan L. Rosenbloom, is with Univ. of Florida, Gainesville. Provides a comprehensive review of current research and developments and addresses the interrelationship of diabetes, obesity, insulin resistance and the metabolic syndrome; clinical and diagnostic issues; epidemiology, pathop
Providing clinicians with the latest developments in research, this new edition of <em>Type 1 Diabetes</em> is a succinct and practical guide to the diagnosis, evaluation, and management of Type 1 diabetes.<br><br>Part of the <em>Oxford Diabetes Library</em> series, this pocketbook contains 12 fully
1 Volume
Content: Preface, Type 2 Diabetes - Disease Overview; Marketed Small Molecule Dipeptidyl Peptidase IV (DPP4) Inhibitors as a New Class of Oral Anti-diabetics; SGLT2 Inhibitors in Development; Glucokinase Activators in Development; 11 -Hydroxysteroid dehydrogenase type 1 (11 -HSD1) inhibitors in deve
The increasing incidence of type II diabetes, often in association with cardiovascular disease, constitutes one of the major healthcare challenges of the 21st century. However, physicians can now deploy a wide range of therapeutic agents, singly and in combination, to help lower and stabilise blood